tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yasmeen Rahimi, 253 are a BUY (95.11%), 13 are a HOLD (4.89%).
Analyst Yasmeen Rahimi, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 27.44% that have a potential upside of 40.02% achieved within 146 days.
Yasmeen Rahimi’s has documented 518 price targets and ratings displayed on 42 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on SAGE, Sage Therapeutic at 30-Oct-2024.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MDGL (MADRIGAL PHARMACEUTICALS) at 11/30/2017. The price target of $82 was fulfilled within 6 days with a profit of $31.66 (62.89%) receiving and performance score of 104.82.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$42
$-2.15 (-4.87%)
$42
1 years 9 months 2 days ago
(15-Feb-2023)
0/15 (0%)
$-2.18 (-4.93%)
Buy
$42
$-2.15 (-4.87%)
$82
1 years 10 months 6 days ago
(11-Jan-2023)
0/4 (0%)
$-2.1 (-4.76%)
Buy
$42
$-2.15 (-4.87%)
$68
1 years 10 months 6 days ago
(11-Jan-2023)
0/3 (0%)
$-2.1 (-4.76%)
Hold
$55
1 years 10 months 6 days ago
(11-Jan-2023)
0/1 (0%)
$36.77 (201.70%)
Hold
$42
$-2.15 (-4.87%)
$61
1 years 10 months 8 days ago
(09-Jan-2023)
0/2 (0%)
$-1.85 (-4.22%)
Which stock is Yasmeen Rahimi is most bullish on?
Which stock is Yasmeen Rahimi is most reserved on?
What Year was the first public recommendation made by Yasmeen Rahimi?
